期刊文献+

胰腺导管腺癌中胰腺星形细胞的研究进展 被引量:2

Research progress of pancreatic stellate cell in pancreatic ductal adenocarcinoma
下载PDF
导出
摘要 胰腺星形细胞(pancreatic stellate cells,PSC)是胰腺导管腺癌(pancreatic ductal adenocarcinoma,PDAC)肿瘤微环境中最重要的成分,在PDAC发生发展中具有非常关键的作用。目前大量研究关注于PSC与胰腺癌细胞(pancreatic cancer cells,PCC)之间的相互作用及PSC在PDAC微环境中发挥的作用。PSC在许多情况下发生活化,如乙醇、氧化应激和高血糖等。PDAC早期即可出现PSC的活化,PCC可以诱导刺激PSC发生活化,活化的PSC可以产生大量胶原纤维,形成适宜PCC生长的间质微环境,促进PCC的增殖,减少化疗药物对肿瘤细胞的杀伤作用。另外,PSC还可以与间质中各种细胞成分如内皮细胞和各种免疫细胞相互作用,在血管生成、免疫逃逸和神经侵犯等方面协助肿瘤进展。因此,阐明PSC与肿瘤细胞以及其他间质成分之间复杂的相互作用至关重要。 Pancreatic stellate cells(PSC) is the most vital element in the stroma of pancreatic ductal adenocarcinoma(PDAC), which plays an irreplaceable role in the development of pancreatic carcinoma. Recent researches concentrate on the interaction between PSC and pancreatic cancer cells(PCC) and the function of PSC in PDAC microenvironment. PSC could be stimulated to activate in some conditions, such as alcohol, oxidative stress and hyperglycemia, etc. PSC activation could be occurred at the early stage of PDAC and would generate collagen to form tumor associated microenvironment, which would accelerate the proliferation of tumor cells and defended the cytotoxicity of chemotherapeutic drugs. Besides, PSC can also interact with other stroma compositions such as endothelial cells and immune cells to form the tumor stroma(e.g., angiogenesis, immune escape and neural invasion), which assists the invasion of cancer cells. Above all, it is pivotal to clarify the interplay between PSC and PDAC as well as stroma ingredients.
出处 《临床与病理杂志》 2017年第9期1971-1977,共7页 Journal of Clinical and Pathological Research
基金 分子病理研究中心创新基金(2016ZX0176-1)~~
关键词 胰腺星形细胞 胰腺导管腺癌 相互作用 肿瘤微环境 pancreatic stellate cells pancreatic cancer interaction tumor microenvironment
  • 相关文献

参考文献1

二级参考文献10

  • 1Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 2Andrew Scott Paulson,Hop S. Tran Cao,Margaret A. Tempero,Andrew M. Lowy.Therapeutic Advances in Pancreatic Cancer[J].Gastroenterology.2013(6)
  • 3Abasi Ene-Obong,Andrew J. Clear,Jennifer Watt,Jun Wang,Rewas Fatah,John C. Riches,John F. Marshall,Joanne Chin-Aleong,Claude Chelala,John G. Gribben,Alan G. Ramsa,Hemant M. Kocher.Activated Pancreatic Stellate Cells Sequester CD8+ T-Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma[J].Gastroenterology.2013
  • 4Minoti V. Apte,Jeremy S. Wilson,Aurelia Lugea,Stephen J. Pandol.A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment[J].Gastroenterology.2013(6)
  • 5Rosa F. Hwang,Todd T. Moore,Maureen Mertens Hattersley,Meghan Scarpitti,Bin Yang,Erik Devereaux,Vijaya Ramachandran,Thiruvengadam Arumugam,Baoan Ji,Craig D. Logsdon,Jeffrey L. Brown,Robert Godin.Inhibition of the Hedgehog Pathway Targets the Tumor-Associated Stroma in Pancreatic Cancer[J].Molecular Cancer Research.2012(9)
  • 6Cindy Neuzillet,Annemila? Tijeras-Raballand,Jér?me Cros,Sandrine Faivre,Pascal Hammel,Eric Raymond.Stromal expression of SPARC in pancreatic adenocarcinoma[J].Cancer and Metastasis Reviews (-).2013(3-4)
  • 7Ruth Maron,Bilha Schechter,Maicol Mancini,Georg Mahlknecht,Yosef Yarden,Michael Sela.Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2[J].Proceedings of the National Academy of Sciences.2013(38)
  • 8Sherri Smith,Jennifer Hoyt,Nigel Whitebread,Joseph Manna,Marisa Peluso,Kerrie Faia,Veronica Campbell,Martin Tremblay,Somarajan Nair,Michael Grogan,Alfredo Castro,Matthew Campbell,Jeanne Ferguson,Brendan Arsenault,Jylle Nevejans,Bennett Carter,John Lee,Joi Dunbar,Karen McGovern,Margaret Read,Julian Adams,Alexander Constan,Gordon Loewen,Jens Sydor,Vito Palombella,John Soglia.The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway[J].Xenobiotica.2013(10)
  • 9Denise A. Yardley.nab -Paclitaxel mechanisms of action and delivery[J].Journal of Controlled Release.2013(3)
  • 10Atsushi Masamune,Shin Hamada,Kazuhiro Kikuta,Tetsuya Takikawa,Shin Miura,Eriko Nakano,Tooru Shimosegawa.The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice[J].Scandinavian Journal of Gastroenterology.2013(5)

共引文献10

同被引文献1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部